Our cohort study proves the effectiveness of systematic hs-cTnT screening for high-risk patients at a university hospital, revealing a high PMI prevalence, especially in patients with a history of cardiovascular risk factors (CVRF) or cardiovascular disease (CVD). Here, TNNT2 is linked to cardiovascular disorder.